• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭的分子机制及干预方法(综述)

Molecular mechanisms and intervention approaches of heart failure (Review).

作者信息

Guo Shuang, Hu Yingqing, Ling Li, Yang Zhuangzhuang, Wan Luxuan, Yang Xiaosong, Lei Min, Guo Xiying, Ren Zhanhong

机构信息

Hubei Key Laboratory of Diabetes and Angiopathy, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei 437100, P.R. China.

School of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei 437100, P.R. China.

出版信息

Int J Mol Med. 2025 Aug;56(2). doi: 10.3892/ijmm.2025.5566. Epub 2025 Jun 13.

DOI:10.3892/ijmm.2025.5566
PMID:40511535
Abstract

Heart failure is a major health issue that threatens life and health. Previous studies have shown that heart failure is the terminal stage of arrhythmia, dilated cardiomyopathy, hypertension, hypertrophic cardiomyopathy and myocardial infarction. The pathological mechanisms through which cardiovascular diseases result in heart failure include myocardial fibrosis and hypertrophy, myocardial cell death, mitochondrial dysfunction, vascular remodeling and calcium dysregulation. However, the detailed molecular mechanisms of heart failure remain elusive because of its complexity, hindering the development of intervention approaches for heart failure. The present study reviewed recent research progress on heart failure and provided references and strategies for the prevention and treatment of heart failure.

摘要

心力衰竭是一个威胁生命健康的重大健康问题。先前的研究表明,心力衰竭是心律失常、扩张型心肌病、高血压、肥厚型心肌病和心肌梗死的终末期阶段。心血管疾病导致心力衰竭的病理机制包括心肌纤维化和肥厚、心肌细胞死亡、线粒体功能障碍、血管重塑和钙调节异常。然而,由于心力衰竭的复杂性,其详细的分子机制仍不清楚,这阻碍了心力衰竭干预方法的发展。本研究综述了心力衰竭的最新研究进展,并为心力衰竭的预防和治疗提供了参考和策略。

相似文献

1
Molecular mechanisms and intervention approaches of heart failure (Review).心力衰竭的分子机制及干预方法(综述)
Int J Mol Med. 2025 Aug;56(2). doi: 10.3892/ijmm.2025.5566. Epub 2025 Jun 13.
2
Antiplatelet versus anticoagulation treatment for people with heart failure in sinus rhythm.窦性心律心力衰竭患者的抗血小板治疗与抗凝治疗对比
Cochrane Database Syst Rev. 2025 Jun 11;6(6):CD003333. doi: 10.1002/14651858.CD003333.pub4.
3
[Shenge powder inhibits myocardial fibrosis in rats with post-myocardial infarction heart failure through LOXL2/TGF-β1/IL-11 signaling pathway].参葛散通过LOXL2/TGF-β1/IL-11信号通路抑制心肌梗死后心力衰竭大鼠的心肌纤维化
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 May 25;54(3):350-359. doi: 10.3724/zdxbyxb-2024-0606.
4
Aficamten in the treatment of obstructive hypertrophic cardiomyopathy.阿非卡坦治疗梗阻性肥厚型心肌病。
Future Cardiol. 2025 Jun 18:1-7. doi: 10.1080/14796678.2025.2521183.
5
Peritoneal dialysis versus haemodialysis for people commencing dialysis.腹膜透析与血液透析治疗开始透析的患者。
Cochrane Database Syst Rev. 2024 Jun 20;6(6):CD013800. doi: 10.1002/14651858.CD013800.pub2.
6
Stakeholders' perceptions and experiences of factors influencing the commissioning, delivery, and uptake of general health checks: a qualitative evidence synthesis.利益相关者对影响一般健康检查的委托、提供和接受因素的看法与体验:一项定性证据综合分析
Cochrane Database Syst Rev. 2025 Mar 20;3(3):CD014796. doi: 10.1002/14651858.CD014796.pub2.
7
Activated cardiac fibroblasts are a primary source of high-molecular-weight hyaluronan production.活化的心脏成纤维细胞是高分子量透明质酸产生的主要来源。
Am J Physiol Cell Physiol. 2025 Mar 1;328(3):C939-C953. doi: 10.1152/ajpcell.00786.2024. Epub 2025 Jan 27.
8
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.基于分子特征的腹膜后脂肪肉瘤分类:一项前瞻性队列研究。
Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887.
9
Muscle-specific isoforms of FXR1 are necessary for miR-1-mediated repression of connexin 43 and are downregulated in pediatric dilated cardiomyopathy.FXR1的肌肉特异性亚型对于miR-1介导的连接蛋白43的抑制是必需的,并且在小儿扩张型心肌病中下调。
Am J Physiol Heart Circ Physiol. 2025 Jun 1;328(6):H1380-H1390. doi: 10.1152/ajpheart.00885.2024. Epub 2025 May 5.
10
[Effects of "new" antidiabetic drugs on management of anesthesia].["新型"抗糖尿病药物对麻醉管理的影响]
Anaesthesiologie. 2025 Mar 31. doi: 10.1007/s00101-025-01521-w.

引用本文的文献

1
Biomarkers in Heart Failure: A Review and a Wish.心力衰竭中的生物标志物:综述与期望
Int J Mol Sci. 2025 Aug 20;26(16):8046. doi: 10.3390/ijms26168046.
2
Special Issue "Cellular and Molecular Biology of Cardiac Hypertrophy and Heart Failure: Pathogenesis, Diagnostics and Treatment".特刊“心肌肥厚与心力衰竭的细胞和分子生物学:发病机制、诊断与治疗”
Int J Mol Sci. 2025 Jul 17;26(14):6865. doi: 10.3390/ijms26146865.

本文引用的文献

1
Association Between Phenotypic Age and the Risk of Mortality in Patients With Heart Failure: A Retrospective Cohort Study.心力衰竭患者表型年龄与死亡风险的关联:一项回顾性队列研究
Clin Cardiol. 2024 Aug;47(8):e24321. doi: 10.1002/clc.24321.
2
Cardiac Hypertrophy: From Pathophysiological Mechanisms to Heart Failure Development.心脏肥大:从病理生理机制到心力衰竭的发展
Rev Cardiovasc Med. 2022 May 6;23(5):165. doi: 10.31083/j.rcm2305165. eCollection 2022 May.
3
Relaxin suppresses atrial fibrillation, reverses fibrosis and reduces inflammation in aged hearts.
松弛素可抑制心房颤动,逆转老年心脏的纤维化并减少炎症。
Biochem Pharmacol. 2024 Sep;227:116407. doi: 10.1016/j.bcp.2024.116407. Epub 2024 Jul 3.
4
Mitochondrial Structure and Function in Human Heart Failure.线粒体结构和功能在人类心力衰竭中的作用。
Circ Res. 2024 Jul 5;135(2):372-396. doi: 10.1161/CIRCRESAHA.124.323800. Epub 2024 Jul 4.
5
Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches.心肌细胞程序性死亡在心血管疾病中的作用及新的治疗方法。
Pharmacol Res. 2024 Aug;206:107281. doi: 10.1016/j.phrs.2024.107281. Epub 2024 Jun 26.
6
Advanced Cardiac Patches for the Treatment of Myocardial Infarction.高级心脏补片治疗心肌梗死。
Circulation. 2024 Jun 18;149(25):2002-2020. doi: 10.1161/CIRCULATIONAHA.123.067097. Epub 2024 Jun 17.
7
Fibroblast-localized lncRNA CFIRL promotes cardiac fibrosis and dysfunction in dilated cardiomyopathy.成纤维细胞特异性长链非编码 RNA CFIRL 促进扩张型心肌病中的心脏纤维化和功能障碍。
Sci China Life Sci. 2024 Jun;67(6):1155-1169. doi: 10.1007/s11427-023-2452-2. Epub 2024 Feb 28.
8
Cryo-EM structure of human HCN3 channel and its regulation by cAMP.人类 HCN3 通道的冷冻电镜结构及其受 cAMP 的调节。
J Biol Chem. 2024 Jun;300(6):107288. doi: 10.1016/j.jbc.2024.107288. Epub 2024 Apr 16.
9
Systematic Review Article: New Drug Strategies for Treating Resistant Hypertension-the Importance of a Mechanistic, Personalized Approach.系统评价文章:治疗顽固性高血压的新药策略——基于机制的个性化方法的重要性。
High Blood Press Cardiovasc Prev. 2024 Mar;31(2):99-112. doi: 10.1007/s40292-024-00634-4. Epub 2024 Apr 14.
10
Stem Cell Therapy against Ischemic Heart Disease.干细胞治疗缺血性心脏病。
Int J Mol Sci. 2024 Mar 28;25(7):3778. doi: 10.3390/ijms25073778.